MedTrace Logo

Observational Study of Actigraphy in Pediatric Pulmonary Arterial Hypertension

NCT04745000 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 43

Last updated 2023-05-10

No results posted yet for this study

Summary

This study plans to learn more about activity levels in children with pulmonary hypertension. Pulmonary hypertension is a condition where the pressure in the lungs is higher than normal. This can affect the person's heart. The purpose of this study is to see if measuring activity in children with pulmonary hypertension and comparing it to activity in children without pulmonary hypertension can give their doctor helpful information on how they are feeling and how their treatment is working.

Conditions

  • Hypertension;Pulmonary;Primary

Sponsors & Collaborators

  • Food and Drug Administration (FDA)

    collaborator FED

  • Children's Hospital Colorado

    collaborator OTHER

  • University of Colorado, Denver

    lead OTHER

Principal Investigators

  • Dunbar Ivy, MD · University of Colorado, Denver

Eligibility

Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-02-11
Primary Completion
2022-04-14
Completion
2022-04-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04745000 on ClinicalTrials.gov